On May 15, 2018, the Senate Committee on Health, Education, Labor and Pensions held a hearing entitled “Examining Oversight Report on the 340B Drug Pricing Program.” Led by Subcommittee Chairman Sen. Lamar Alexander (R-TN),...more
On October 11, 2017, the House Energy & Commerce’s Oversight and Investigations Subcommittee held a hearing entitled “Examining How Covered Entities Utilize the 340B Drug Pricing Program.” This was the Subcommittee’s second...more
On July 18, 2017, the House Energy & Commerce’s Oversight and Investigations Subcommittee held a hearing on “Examining HRSA’s Oversight of the 340B Drug Pricing Program.” The hearing featured a single panel of three federal...more